Sulfonylurea Effects on Glucagon Regulation During Hypoglycemia in Type 1 DM

NCT00515801 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: glibenclamide
DRUG: placebo

Sponsor

University Hospital, Basel, Switzerland